CD4 + T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease
We previously detected HIV-1 Gag-specific CD4 + T cells recognizing reference strain viral epitopes in subjects with progressive, chronic infection. To test whether these CD4 + T cells persist in vivo by failing to recognize autologous HIV-1 epitopes, we compared autologous plasma HIV-1 p24 nucleoti...
Saved in:
Published in | Virology (New York, N.Y.) Vol. 361; no. 1; pp. 34 - 44 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
25.04.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We previously detected HIV-1 Gag-specific CD4
+ T cells recognizing reference strain viral epitopes in subjects with progressive, chronic infection. To test whether these CD4
+ T cells persist
in vivo by failing to recognize autologous HIV-1 epitopes, we compared autologous plasma HIV-1 p24 nucleotide sequences with targeted HXB.2 strain Gag p24 CD4
+ T cell epitopes in nine chronically infected, untreated subjects. In five responding subjects, 10 of 26 HXB.2 strain p24 peptides targeted by CD4
+ T cells exactly matched autologous plasma viral sequences. Four subjects with plasma viral loads >
100,000 copies/mL had no measurable p24-specific CD4
+ T cell responses despite carrying HIV-1 strains that matched HXB.2 sequences at predicted epitopes. These results show that HIV-1-specific CD4
+ T cells can persist in chronic HIV-1 infection despite recognition of epitopes present
in vivo. However, with high-level
in vivo HIV-1 replication, CD4
+ T cells targeting autologous HIV-1 may be non-responsive or absent. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Department of Medicine, Residency Program Office, 1830 East Monument Street/Suite 9020, Baltimore, MD 21287. Email: eboritz1@jhmi.edu |
ISSN: | 0042-6822 1096-0341 |
DOI: | 10.1016/j.virol.2006.10.040 |